Christine Menetrier-Caux

Christine Menetrier-Caux

UNVERIFIED PROFILE

Are you Christine Menetrier-Caux?   Register this Author

Register author
Christine Menetrier-Caux

Christine Menetrier-Caux

Publications by authors named "Christine Menetrier-Caux"

Are you Christine Menetrier-Caux?   Register this Author

38Publications

870Reads

48Profile Views

Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function.

Front Immunol 2019 6;10:925. Epub 2019 Jun 6.

Department of Oncology, Ludwig Institute for Cancer Research Lausanne, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fimmu.2019.00925DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562565PMC
June 2019

CD73 expression in normal and pathological human hepatobiliopancreatic tissues.

Cancer Immunol Immunother 2019 Mar 4;68(3):467-478. Epub 2019 Jan 4.

Service of Clinical Pathology, Institute of Pathology, Lausanne University Hospital, rue du Bugnon 25, 1011, Lausanne, Switzerland.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00262-018-2290-1
Publisher Site
http://dx.doi.org/10.1007/s00262-018-2290-1DOI Listing
March 2019

Correction to: CD73 expression in normal and pathological human hepatobiliopancreatic tissues.

Cancer Immunol Immunother 2019 03;68(3):529

Service of Clinical Pathology, Institute of Pathology, Lausanne University Hospital, rue du Bugnon 25, 1011, Lausanne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-019-02309-9DOI Listing
March 2019

Lymphopenia in Cancer Patients and its Effects on Response to Immunotherapy: an opportunity for combination with Cytokines?

J Immunother Cancer 2019 Mar 28;7(1):85. Epub 2019 Mar 28.

Univ Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Cancer Research Center of Lyon (CRCL), Centre Léon Bérard, F-69008, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40425-019-0549-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437964PMC
March 2019

MDR1 in immunity: friend or foe?

Oncoimmunology 2018 6;7(12):e1499388. Epub 2018 Sep 6.

Centre Léon Bérard, Cancer Research Center of Lyon (CRCL), Univ Lyon, Université Claude Bernard Lyon 1, Lyon France.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/2162402X.2018.1
Publisher Site
http://dx.doi.org/10.1080/2162402X.2018.1499388DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6279327PMC
September 2018

A Milestone Review on How Macrophages Affect Tumor Growth.

Cancer Res 2016 11;76(22):6439-6442

Innovation in Immuno-monitoring and Immunotherapy Platform (PI3), Léon Bérard Cancer Center, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-16-2631DOI Listing
November 2016

Follicular B Lymphomas Generate Regulatory T Cells via the ICOS/ICOSL Pathway and Are Susceptible to Treatment by Anti-ICOS/ICOSL Therapy.

Cancer Res 2016 08 31;76(16):4648-60. Epub 2016 May 31.

Centre de recherche en Cancérologie de Marseille, Inserm U1068/CNRS U7258, Marseille, France. Aix Marseille Université, Marseille, France. Institut Paoli - Calmettes, Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-15-0589DOI Listing
August 2016

Disequilibrium of BMP2 levels in the breast stem cell niche launches epithelial transformation by overamplifying BMPR1B cell response.

Stem Cell Reports 2015 Feb 15;4(2):239-54. Epub 2015 Jan 15.

CNRS UMR5286, Centre de Recherche en Cancérologie de Lyon, 69000 Lyon, France; Inserm U1052, Centre de Recherche en Cancérologie de Lyon, 69000 Lyon, France; Université de Lyon, 69000 Lyon, France; Department of Immunity, Virus, and Microenvironment, 69000 Lyon, France; Université de Lyon 1, ISPB, 69000 Lyon, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.stemcr.2014.12.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4325271PMC
February 2015

ICOS is associated with poor prognosis in breast cancer as it promotes the amplification of immunosuppressive CD4 T cells by plasmacytoid dendritic cells.

Oncoimmunology 2013 Mar;2(3):e23185

Université de Lyon; Lyon, France ; ISPB; Université de Lyon 1; Lyon, France ; INSERM U1052; Centre de Recherche en Cancérologie de Lyon; Lyon, France ; CNRS UMR5286; Centre de Recherche en Cancérologie de Lyon; Lyon, France ; LabEx DEVweCAN; Lyon, France ; Centre Léon Bérard; Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/onci.23185DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3661154PMC
March 2013

Plasmacytoid dendritic cells deficient in IFNα production promote the amplification of FOXP3 regulatory T cells and are associated with poor prognosis in breast cancer patients.

Oncoimmunology 2013 Jan;2(1):e22338

Université de Lyon; Lyon, France ; Université Lyon 1; ISPB; Lyon, France ; INSERM U1052; Centre de Recherche en Cancérologie de Lyon; Lyon, France ; CNRS UMR5286; Centre de Recherche en Cancérologie de Lyon; Lyon, France ; LabEx DEVweCAN; Lyon, France ; Centre Léon Bérard; Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/onci.22338DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583914PMC
January 2013

Innate immune recognition of breast tumor cells mediates CCL22 secretion favoring Treg recruitment within tumor environment.

Oncoimmunology 2012 Aug;1(5):759-761

Université de Lyon; Lyon, France ; Université Lyon 1; ISPB; Lyon, France ; Team 11; CRCL INSERM U-1052/CNRS 5286; Lyon, France ; LabEx DEVweCAN; Centre Léon Bérard; Lyon, France ; Centre Léon Bérard; Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/onci.19680DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3429586PMC
August 2012

Targeting regulatory T cells.

Target Oncol 2012 Mar 12;7(1):15-28. Epub 2012 Feb 12.

Université de Lyon, F-69000, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11523-012-0208-yDOI Listing
March 2012

C/EBP{delta} and STAT-1 are required for TLR8 transcriptional activity.

J Biol Chem 2010 Nov 9;285(45):34773-80. Epub 2010 Sep 9.

Infection and Cancer Biology Group, International Agency for Research on Cancer, Lyon 69008, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M110.133884DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2966093PMC
November 2010

Differences in tumor regulatory T-cell localization and activation status impact patient outcome.

Cancer Res 2009 Oct 6;69(20):7895-8. Epub 2009 Oct 6.

Inserm, U590, Centre Léon Bérard, Equipe Cytokines et Cancers, Université Lyon 1, ISPB, and IFR62, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-09-1642DOI Listing
October 2009

Cell proliferation and survival induced by Toll-like receptors is antagonized by type I IFNs.

Proc Natl Acad Sci U S A 2007 May 26;104(19):8047-52. Epub 2007 Apr 26.

Infections and Cancer Biology Group, International Agency for Research on Cancer (IARC-WHO), 150 Cours Albert Thomas, 69372 Lyon Cedex 08, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.0700664104DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1876569PMC
May 2007

IL-6 as an intracrine growth factor for renal carcinoma cell lines.

Int J Cancer 2004 Sep;111(5):653-61

Equipe Cytokine et Cancer, Unité INSERM 590, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.20287DOI Listing
September 2004

Long-lived immature dendritic cells mediated by TRANCE-RANK interaction.

Blood 2002 Nov 5;100(10):3646-55. Epub 2002 Jul 5.

Institut National de la Santé et de la Recherche Médicale (INSERM) U255, Centre de Recherches Biomédicales des Cordeliers, and Unité de Génétique Mycobactérienne, Institut Pasteur, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2002-01-0312DOI Listing
November 2002